Tue, February 20, 2024
Mon, February 19, 2024
Fri, February 16, 2024
Thu, February 15, 2024

Mohit Bansal Maintained (TVTX) at Hold with Increased Target to $9 on, Feb 16th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-9-on-feb-16th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Mohit Bansal of Wells Fargo, Maintained "Travere Therapeutics, Inc." (TVTX) at Hold with Increased Target from $8 to $9 on, Feb 16th, 2024.

Mohit has made no other calls on TVTX in the last 4 months.



There are 4 other peers that have a rating on TVTX. Out of the 4 peers that are also analyzing TVTX, 2 agree with Mohit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Nicole Gabreski of "Piper Sandler" Maintained at Hold with Increased Target to $11 on, Thursday, January 18th, 2024
  • Alex Thompson of "Stifel" Maintained at Hold with Increased Target to $10 on, Monday, December 18th, 2023


These are the ratings of the 2 analyists that currently disagree with Mohit


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Friday, December 15th, 2023
  • Carly Kenselaar of "Citigroup" Upgraded from Hold to Strong Buy and Increased Target to $10 on, Tuesday, December 5th, 2023

Publication Contributing Sources